Comparative evaluation of complement factor D and C3 inhibitors on serum bactericidal activity against nongroupable Neisseria meningitidis

被引：0
作者：
Zhao, Yongsen [1 ]
机构：
[1] Alex Pharmaceut, New Haven, CT USA
来源：
MOLECULAR IMMUNOLOGY | 2022年 / 141卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
78
引用
收藏
页码：149 / 150
页数：2
相关论文
共 50 条
  • [41] Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis
    Anna M. Blom
    Fernando Corvillo
    Michal Magda
    Grzegorz Stasiłojć
    Pilar Nozal
    Miguel Ángel Pérez-Valdivia
    Virginia Cabello-Chaves
    Santiago Rodríguez de Córdoba
    Margarita López-Trascasa
    Marcin Okrój
    Journal of Clinical Immunology, 2016, 36 : 517 - 527
  • [42] Neisseria meningitidis Serogroup B Vaccine, Bivalent rLP2086, Induces Broad Serum Bactericidal Activity Against Diverse Invasive Disease Strains Including Outbreak Strains
    Harris, Shannon L.
    Donald, Robert G. K.
    Hawkins, Julio Cesar
    Tan, Cuiwen
    O'Neill, Robert
    McNeil, Lisa K.
    Perez, John L.
    Anderson, Annaliesa S.
    Jansen, Kathrin U.
    Jones, Thomas R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (02) : 216 - 223
  • [43] Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk
    Heurich, Meike
    Martinez-Barricarte, Ruben
    Francis, Nigel J.
    Roberts, Dawn L.
    Rodriguez de Cordoba, Santiago
    Morgan, B. Paul
    Harris, Claire L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (21) : 8761 - 8766
  • [44] Distinctive dosage requirements between C3 and Factor D (FD) in the activation of the alternative complement pathway
    Wu, Xiaobo
    Hu, Zheng
    Xu, Thomas
    Atkinson, John
    IMMUNOBIOLOGY, 2023, 228 (05) : 45 - 45
  • [45] Serum C3 complement levels predict prognosis and monitor disease activity in Guillain-Barre syndrome
    Min, Young Gi
    Ju, Woohee
    Seo, Jae-Woo
    Ha, Ye-Eun
    Ban, Jae-Jun
    Kwon, Young Nam
    Jeong, Han-Yeong
    Shin, Je-Young
    Kim, Sung-Min
    Hong, Yoon-Ho
    Kim, Sang-Jeong
    Sung, Jung-Joon
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 444
  • [46] Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis
    Désirée Tampe
    Eva Baier
    Samy Hakroush
    Björn Tampe
    Journal of Nephrology, 2023, 36 : 125 - 132
  • [47] SPECIFIC CYTOLYTIC ACTIVITY OF LYMPHOCYTES - EFFECT OF ANTIBODIES AGAINST COMPLEMENT COMPONENTS C2, C3, AND C5
    HENNEY, CS
    MAYER, MM
    CELLULAR IMMUNOLOGY, 1971, 2 (06) : 702 - &
  • [48] SERUM LEVELS OF COMPONENTS C3 AND C4 OF COMPLEMENT IN CHILDREN WITH CYTOMEGALIC INCLUSION DISEASE WITH PREVALENT HEPATIC ACTIVITY
    BALLATI, G
    CASTELLO, MA
    SABETTA, G
    MIDULLA, M
    MINERVA PEDIATRICA, 1975, 27 (11) : 663 - 667
  • [49] Haemolytic complement activity, C3 and Factor B consumption in serum from chickens divergently selected for antibody responses to sheep red blood cells
    Parmentier, HK
    Baelmans, R
    Nieuwland, MGB
    Dorny, P
    Demey, F
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2002, 90 (1-2) : 91 - 100
  • [50] In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway
    Ispasanie, Emma
    Muri, Lukas
    Schmid, Marc
    Schubart, Anna
    Thorburn, Christine
    Zamurovic, Natasa
    Holbro, Thomas
    Kammueller, Michael
    Pluschke, Gerd
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345